A citation-based method for searching scientific literature

Joshua K Sabari, Michael Offin, Dennis Stephens, Andy Ni, Adrian Lee, Nick Pavlakis, Stephen Clarke, Connie I Diakos, Sutirtha Datta, Nidhi Tandon, Andres Martinez, Mackenzie L Myers, Alex Makhnin, Ysleni Leger, Helena A Yu, Paul K Paik, Jamie E Chaft, Mark G Kris, Jeong O Jeon, Laetitia A Borsu, Marc Ladanyi, Maria E Arcila, Jennifer Hernandez, Samantha Henderson, Tristan Shaffer, Kavita Garg, Dan DiPasquo, Christopher K Raymond, Lee P Lim, Mark Li, Matthew D Hellmann, Alexander Drilon, Gregory J Riely, Valerie W Rusch, David R Jones, Andreas Rimner, Charles M Rudin, James M Isbell, Bob T Li. J Natl Cancer Inst 2019
Times Cited: 51







List of co-cited articles
364 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Concurrent EGFR-TKI and Thoracic Radiotherapy as First-Line Treatment for Stage IV Non-Small Cell Lung Cancer Harboring EGFR Active Mutations.
LinPeng Zheng, Yanmei Wang, Zihan Xu, Qiao Yang, Guangkuo Zhu, Xing-Yun Liao, Xiewan Chen, Bo Zhu, Yuzhong Duan, Jianguo Sun. Oncologist 2019
23
4

Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions.
Nicolas Floc'h, Matthew J Martin, Jonathan W Riess, Jonathan P Orme, Anna D Staniszewska, Ludovic Ménard, Maria Emanuela Cuomo, Daniel J O'Neill, Richard A Ward, M Raymond V Finlay,[...]. Mol Cancer Ther 2018
47
2

Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.
Kari J Kurppa, Yao Liu, Ciric To, Tinghu Zhang, Mengyang Fan, Amir Vajdi, Erik H Knelson, Yingtian Xie, Klothilda Lim, Paloma Cejas,[...]. Cancer Cell 2020
77
1

In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer.
Toshiyuki Hirano, Hiroyuki Yasuda, Tetsuo Tani, Junko Hamamoto, Ayano Oashi, Kota Ishioka, Daisuke Arai, Shigenari Nukaga, Masayoshi Miyawaki, Ichiro Kawada,[...]. Oncotarget 2015
89
1

Ultra-sensitive EGFR T790M Detection as an Independent Prognostic Marker for Lung Cancer Patients Harboring EGFR del19 Mutations and Treated with First-generation TKIs.
Julie A Vendrell, Julien Mazieres, Romain Senal, Isabelle Rouquette, Xavier Quantin, Jean-Louis Pujol, Benoit Roch, Abdelali Bouidioua, Sylvain Godreuil, Etienne Coyaud,[...]. Clin Cancer Res 2019
15
6

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC.
Jiyeon Yun, Soo-Hwan Lee, Seok-Young Kim, Seo-Yoon Jeong, Jae-Hwan Kim, Kyoung-Ho Pyo, Chae-Won Park, Seong Gu Heo, Mi Ran Yun, Sangbin Lim,[...]. Cancer Discov 2020
46
2

Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX® HS, a new highly sensitive assay for the MassARRAY® System.
Bobbie C Sutton, Ryan T Birse, Kevin Maggert, Tammy Ray, Jessica Hobbs, Amobi Ezenekwe, Jason Kazmierczak, Michael Mosko, Joan Kish, Andrew Bullock,[...]. PLoS One 2017
9
11



PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy.
Kaiyan Chen, Guoping Cheng, Fanrong Zhang, Guanxia Zhu, Yanjun Xu, Xiaoqing Yu, Zhiyu Huang, Yun Fan. Lung Cancer 2020
18
5

BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors.
Anthony C Faber, Ryan B Corcoran, Hiromichi Ebi, Lecia V Sequist, Belinda A Waltman, Euiheon Chung, Joao Incio, Subba R Digumarthy, Sarah F Pollack, Youngchul Song,[...]. Cancer Discov 2011
217
1

PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project.
H Blons, J-B Oudart, J-P Merlio, D Debieuvre, F de Fraipont, C Audigier-Valette, F Escande, S Hominal, P-P Bringuier, S Fraboulet-Moreau,[...]. Lung Cancer 2021
2
50

Transcriptomic silencing as a potential mechanism of treatment resistance.
Jacob J Adashek, Shumei Kato, Rahul Parulkar, Christopher W Szeto, J Zachary Sanborn, Charles J Vaske, Stephen C Benz, Sandeep K Reddy, Razelle Kurzrock. JCI Insight 2020
11
9

The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal.
Valerio Gristina, Umberto Malapelle, Antonio Galvano, Pasquale Pisapia, Francesco Pepe, Christian Rolfo, Silvia Tortorici, Viviana Bazan, Giancarlo Troncone, Antonio Russo. Cancer Treat Rev 2020
34
2

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines.
Silvia La Monica, Daniele Cretella, Mara Bonelli, Claudia Fumarola, Andrea Cavazzoni, Graziana Digiacomo, Lisa Flammini, Elisabetta Barocelli, Roberta Minari, Nadia Naldi,[...]. J Exp Clin Cancer Res 2017
31
3

Sequencing depth and coverage: key considerations in genomic analyses.
David Sims, Ian Sudbery, Nicholas E Ilott, Andreas Heger, Chris P Ponting. Nat Rev Genet 2014
622
1


AZD9291 promotes autophagy and inhibits PI3K/Akt pathway in NSCLC cancer cells.
Zhirui Zhang, Mengxiao Zhang, Hao Liu, Wu Yin. J Cell Biochem 2019
17
5

Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors.
Alexa B Schrock, Viola W Zhu, Wen-Son Hsieh, Russell Madison, Benjamin Creelan, Jeffrey Silberberg, Dan Costin, Anjali Bharne, Ioana Bonta, Thangavijayan Bosemani,[...]. J Thorac Oncol 2018
60
1

Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs.
Matteo Canale, Elisabetta Petracci, Angelo Delmonte, Giuseppe Bronte, Elisa Chiadini, Vienna Ludovini, Alessandra Dubini, Maximilian Papi, Sara Baglivo, Nicoletta De Luigi,[...]. J Clin Med 2020
15
6


RNA Analysis as a Tool to Determine Clinically Relevant Gene Fusions and Splice Variants.
Cristina Teixidó, Ana Giménez-Capitán, Miguel Ángel Molina-Vila, Vicente Peg, Niki Karachaliou, Alejandra Rodríguez-Capote, Josep Castellví, Rafael Rosell. Arch Pathol Lab Med 2018
11
9

Liquid biopsy approaches for pleural effusion in lung cancer patients.
Gayathri Baburaj, Rama Rao Damerla, Karthik S Udupa, Preetiparna Parida, Murali Munisamy, Jill Kolesar, Mahadev Rao. Mol Biol Rep 2020
6
16

Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing.
Fiamma Buttitta, Lara Felicioni, Maela Del Grammastro, Giampaolo Filice, Alessia Di Lorito, Sara Malatesta, Patrizia Viola, Irene Centi, Tommaso D'Antuono, Roberta Zappacosta,[...]. Clin Cancer Res 2013
81
1

Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA.
Jong Sik Lee, Jae Young Hur, In Ae Kim, Hee Joung Kim, Chang Min Choi, Jae Chol Lee, Wan Seop Kim, Kye Young Lee. BMC Cancer 2018
45
2

Heterogeneity and Coexistence of T790M and T790 Wild-Type Resistant Subclones Drive Mixed Response to Third-Generation Epidermal Growth Factor Receptor Inhibitors in Lung Cancer.
Zofia Piotrowska, Mehlika Hazar-Rethinam, Coleen Rizzo, Brandon Nadres, Emily E Van Seventer, Heather A Shahzade, Inga T Lennes, Anthony J Iafrate, Dora Dias-Santagata, Ignaty Leshchiner,[...]. JCO Precis Oncol 2018
15
6

A Combined test using both cell sediment and supernatant cell-free DNA in pleural effusion shows increased sensitivity in detecting activating EGFR mutation in lung cancer patients.
A Kawahara, C Fukumitsu, K Azuma, T Taira, H Abe, Y Takase, K Murata, E Sadashima, S Hattori, Y Naito,[...]. Cytopathology 2018
21
4

Liquid biopsies using pleural effusion-derived exosomal DNA in advanced lung adenocarcinoma.
Zhengbo Song, Zhijian Cai, Junrong Yan, Yang W Shao, Yiping Zhang. Transl Lung Cancer Res 2019
18
5

FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution.
Aaron M Newman, Scott V Bratman, Henning Stehr, Luke J Lee, Chih Long Liu, Maximilian Diehn, Ash A Alizadeh. Bioinformatics 2014
107
1

Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor.
Zofia Piotrowska, Matthew J Niederst, Chris A Karlovich, Heather A Wakelee, Joel W Neal, Mari Mino-Kenudson, Linnea Fulton, Aaron N Hata, Elizabeth L Lockerman, Anuj Kalsy,[...]. Cancer Discov 2015
341
1

Clinical application of a digital thoracic drainage system for objectifying and quantifying air leak versus the traditional vacuum system: a retrospective observational study.
Song Am Lee, Jun Seok Kim, Hyun Keun Chee, Jae Joon Hwang, Michael Ji, Yo Han Kim, Hyeong Ju Moon, Woo Surng Lee. J Thorac Dis 2021
1
100

A framework for variation discovery and genotyping using next-generation DNA sequencing data.
Mark A DePristo, Eric Banks, Ryan Poplin, Kiran V Garimella, Jared R Maguire, Christopher Hartl, Anthony A Philippakis, Guillermo del Angel, Manuel A Rivas, Matt Hanna,[...]. Nat Genet 2011
1


Comprehensive Genomic Profiling of Malignant Effusions in Patients with Metastatic Lung Adenocarcinoma.
Soo-Ryum Yang, Chieh-Yu Lin, Henning Stehr, Steven R Long, Christina S Kong, Gerald J Berry, James L Zehnder, Christian A Kunder. J Mol Diagn 2018
22
4

Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine.
Giovanna Rossi, Michail Ignatiadis. Cancer Res 2019
64
1

Statistical machine learning of sleep and physical activity phenotypes from sensor data in 96,220 UK Biobank participants.
Matthew Willetts, Sven Hollowell, Louis Aslett, Chris Holmes, Aiden Doherty. Sci Rep 2018
54
1

BCD-WERT: a novel approach for breast cancer detection using whale optimization based efficient features and extremely randomized tree algorithm.
Shafaq Abbas, Zunera Jalil, Abdul Rehman Javed, Iqra Batool, Mohammad Zubair Khan, Abdulfattah Noorwali, Thippa Reddy Gadekallu, Aqsa Akbar. PeerJ Comput Sci 2021
7
14

Exome sequencing and characterization of 49,960 individuals in the UK Biobank.
Cristopher V Van Hout, Ioanna Tachmazidou, Joshua D Backman, Joshua D Hoffman, Daren Liu, Ashutosh K Pandey, Claudia Gonzaga-Jauregui, Shareef Khalid, Bin Ye, Nilanjana Banerjee,[...]. Nature 2020
80
1

Using Wearable Activity Trackers to Predict Type 2 Diabetes: Machine Learning-Based Cross-sectional Study of the UK Biobank Accelerometer Cohort.
Benjamin Lam, Michael Catt, Sophie Cassidy, Jaume Bacardit, Philip Darke, Sam Butterfield, Ossama Alshabrawy, Michael Trenell, Paolo Missier. JMIR Diabetes 2021
2
50

Maftools: efficient and comprehensive analysis of somatic variants in cancer.
Anand Mayakonda, De-Chen Lin, Yassen Assenov, Christoph Plass, H Phillip Koeffler. Genome Res 2018
611
1

In silico learning of tumor evolution through mutational time series.
Noam Auslander, Yuri I Wolf, Eugene V Koonin. Proc Natl Acad Sci U S A 2019
8
12

Ataxin-1 occupies the promoter region of E-cadherin in vivo and activates CtBP2-repressed promoter.
Soyeon Lee, Sunghoi Hong, Sungsu Kim, Seongman Kang. Biochim Biophys Acta 2011
19
5

Choice of control tissue impacts designation of germline variants in a cohort of papillary thyroid carcinoma patients.
J C Rubinstein, N G Nicolson, D Rottmann, R Morotti, R Korah, T Carling, E R Christison-Lagay. Ann Oncol 2020
3
33


Functional equivalence of genome sequencing analysis pipelines enables harmonized variant calling across human genetics projects.
Allison A Regier, Yossi Farjoun, David E Larson, Olga Krasheninina, Hyun Min Kang, Daniel P Howrigan, Bo-Juen Chen, Manisha Kher, Eric Banks, Darren C Ames,[...]. Nat Commun 2018
57
1

Detection of anaemia from retinal fundus images via deep learning.
Akinori Mitani, Abigail Huang, Subhashini Venugopalan, Greg S Corrado, Lily Peng, Dale R Webster, Naama Hammel, Yun Liu, Avinash V Varadarajan. Nat Biomed Eng 2020
28
3

Somatic Mutations Reveal Lineage Relationships and Age-Related Mutagenesis in Human Hematopoiesis.
Fernando G Osorio, Axel Rosendahl Huber, Rurika Oka, Mark Verheul, Sachin H Patel, Karlijn Hasaart, Lisanne de la Fonteijne, Ignacio Varela, Fernando D Camargo, Ruben van Boxtel. Cell Rep 2018
71
1


Immunotherapy for Breast Cancer: What Are We Missing?
Robert H Vonderheide, Susan M Domchek, Amy S Clark. Clin Cancer Res 2017
105
1

Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients.
Florent Mouliere, Richard Mair, Dineika Chandrananda, Francesco Marass, Christopher G Smith, Jing Su, James Morris, Colin Watts, Kevin M Brindle, Nitzan Rosenfeld. EMBO Mol Med 2018
60
1


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.